Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

411 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Immune-monitoring of myelodysplastic neoplasms: Recommendations from the i4MDS consortium.
Tentori CA, Zhao LP, Tinterri B, Strange KE, Zoldan K, Dimopoulos K, Feng X, Riva E, Lim B, Simoni Y, Murthy V, Hayes MJ, Poloni A, Padron E, Cardoso BA, Cross M, Winter S, Santaolalla A, Patel BA, Groarke EM, Wiseman DH, Jones K, Jamieson L, Manogaran C, Daver N, Gallur L, Ingram W, Ferrell PB, Sockel K, Dulphy N, Chapuis N, Kubasch AS, Olsnes AM, Kulasekararaj A, De Lavellade H, Kern W, Van Hemelrijck M, Bonnet D, Westers TM, Freeman S, Oelschlaegel U, Valcarcel D, Raddi MG, Grønbæk K, Fontenay M, Loghavi S, Santini V, Almeida AM, Irish JM, Sallman DA, Young NS, van de Loosdrecht AA, Adès L, Della Porta MG, Cargo C, Platzbecker U, Kordasti S; i4MDS consortium. Tentori CA, et al. Among authors: van hemelrijck m. Hemasphere. 2024 May 15;8(5):e64. doi: 10.1002/hem3.64. eCollection 2024 May. Hemasphere. 2024. PMID: 38756352 Free PMC article.
Previous immune checkpoint inhibitor therapy is associated with decreased COVID-19-related hospitalizations and complications in patients with cancer: Results of a propensity-matched analysis of the OnCovid registry.
Mostaghim A, Minkove S, Aguilar-Company J, Ruiz-Camps I, Eremiev-Eremiev S, Dettorre GM, Fox L, Tondini C, Brunet J, Carmona-García M, Lambertini M, Bower M, Newsom-Davis T, Sharkey R, Pria AD, Rossi M, Plaja A, Salazar R, Sureda A, Prat A, Michalarea V, Van Hemelrijck M, Sita-Lumsden A, Bertuzzi A, Rimassa L, Rossi S, Rizzo G, Pedrazzoli P, Lee AJ, Murphy C, Belessiotis K, Diamantis N, Mukherjee U, Pommeret F, Stoclin A, Martinez-Vila C, Bruna R, Gaidano G, D'Avanzo F, Gennari A, Athale J, Eichacker P, Pinato DJ, Torabi-Parizi P, Cortellini A; OnCovid study group. Mostaghim A, et al. Among authors: van hemelrijck m. Int J Infect Dis. 2024 Feb;139:13-20. doi: 10.1016/j.ijid.2023.11.021. Epub 2023 Nov 27. Int J Infect Dis. 2024. PMID: 38029831 Free article.
Using the Movember Foundation's GAP3 cohort to measure the effect of active surveillance on patient-reported urinary and sexual function-a retrospective study in low-risk prostate cancer patients.
Crump RT, Remmers S, Van Hemelrijck M, Helleman J, Nieboer D, Roobol MJ, Venderbos LDF; Movember Foundation’s Global Action Plan Prostate Cancer Active Surveillance (GAP3) consortium. Crump RT, et al. Among authors: van hemelrijck m. Transl Androl Urol. 2021 Jun;10(6):2719-2727. doi: 10.21037/tau-20-1255. Transl Androl Urol. 2021. PMID: 34295757 Free PMC article.
Real-World Analysis of Survival and Treatment Efficacy in Stage IIIA-N2 Non-Small Cell Lung Cancer.
Josephides E, Dunn R, Henry AR, Pilling J, Harrison-Phipps K, Patel A, Ahmad S, Skwarski M, Spicer J, Georgiou A, Ghosh S, Van Hemelrijck M, Karapanagiotou E, Smith D, Bille A. Josephides E, et al. Among authors: van hemelrijck m. Cancers (Basel). 2024 Sep 2;16(17):3058. doi: 10.3390/cancers16173058. Cancers (Basel). 2024. PMID: 39272916 Free PMC article.
PIONEER big data platform for prostate cancer: lessons for advancing future real-world evidence research.
Lawlor A, Beyer K, Russell B, Steinbeisser C, Bjartell A, De Meulder B, Omar MI, Hulsen T, Butler J, N'Dow J, Rivas JG, Gandaglia G, Nicoletti R, Sakalis V, Smith EJ, Maass M, Zong J, Fullwood L, Abbott T, Tafreshiha A, Papineni K, Snijder R, Horgan D, Seager S, Evans-Axelsson S, Ribal MJ, Roobol MJ, Van Hemelrijck M; PIONEER Consortium. Lawlor A, et al. Among authors: van hemelrijck m. Nat Rev Urol. 2024 Sep 9. doi: 10.1038/s41585-024-00925-4. Online ahead of print. Nat Rev Urol. 2024. PMID: 39251785 Review.
IgE glycosylation and impact on structure and function: A systematic review.
McCraw AJ, Palhares LCGF, Hendel JL, Gardner RA, Santaolalla A, Crescioli S, McDonnell J, Van Hemelrijck M, Chenoweth A, Spencer DIR, Wagner GK, Karagiannis SN. McCraw AJ, et al. Among authors: van hemelrijck m. Allergy. 2024 Aug 4. doi: 10.1111/all.16259. Online ahead of print. Allergy. 2024. PMID: 39099223 Review.
Beyond the Timeline: One-year Mortality Trends in Early vs. Late Prosthetic Valve Endocarditis.
Papadimitriou-Olivgeris M, Ledergerber B, Siedentop B, Monney P, Frank M, Tzimas G, Tozzi P, Kirsch M, Epprecht J, van Hemelrijck M, Dzemali O, Guery B, Hasse B. Papadimitriou-Olivgeris M, et al. Among authors: van hemelrijck m. Clin Infect Dis. 2024 Jul 27:ciae392. doi: 10.1093/cid/ciae392. Online ahead of print. Clin Infect Dis. 2024. PMID: 39067056
Has Active Surveillance for Prostate Cancer Become Safer? Lessons Learned from a Global Clinical Registry.
Bangma C, Doan P, Zhu L, Remmers S, Nieboer D, Helleman J, Roobol MJ, Sugimoto M, Chung BH, Lee LS, Frydenberg M, Klotz L, Peacock M, Perry A, Bjartell A, Rannikko A, Van Hemelrijck M, Dasgupta P, Moore C, Trock BJ, Pavlovich C, Steyerberg E, Carroll P, Koo KC, Hayen A, Thompson J; Movember Foundation’s Global Action Plan Prostate Cancer Active Surveillance (GAP3) Consortium. Bangma C, et al. Among authors: van hemelrijck m. Eur Urol Oncol. 2024 Jul 17:S2588-9311(24)00176-7. doi: 10.1016/j.euo.2024.07.003. Online ahead of print. Eur Urol Oncol. 2024. PMID: 39025687 Free article.
Comparison of the 2015 and 2023 European Society of Cardiology versions of the Duke criteria among patients with suspected infective endocarditis.
Papadimitriou-Olivgeris M, Monney P, Frank M, Tzimas G, Fourre N, Zimmermann V, Tozzi P, Kirsch M, Van Hemelrijck M, Epprecht J, Guery B, Hasse B. Papadimitriou-Olivgeris M, et al. Among authors: van hemelrijck m. Clin Infect Dis. 2024 Jul 12:ciae370. doi: 10.1093/cid/ciae370. Online ahead of print. Clin Infect Dis. 2024. PMID: 38997115
411 results